SCHEMBL4738027

SCHEMBL4738027

CN(C)CCNS(=O)(=O)c1ccc(Nc2ncc3cc(Br)ccc3n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 5/20 0.55
▸ CDK2 P24941 5/20 0.54
▸ CDK4 P11802 3/20 0.51
▸ CDK1 P06493 3/20 0.51
▸ SRC P12931 2/20 0.51
▸ BRAF P15056 4/20 0.48
▸ CCNA2 P20248 1/20 0.47
▸ CDK6 Q00534 1/20 0.47
▸ TSHR P16473 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ CCNB2 O95067 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ CCNB3 Q8WWL7 1/20 0.46
▸ GAA P10253 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.43
▸ CHUK O15111 1/20 0.42
▸ NEK1 Q96PY6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735339 0.82 BRAF (0.58) IKBKBCDK2CDK4CDK1SRC
SCHEMBL1570769 0.79 CA2 (0.52) IKBKBCDK2CDK4CDK1CCNA2
SCHEMBL12120858 0.78 BRAF (0.53) CDK1BRAF
SCHEMBL5505032 0.76 EGFR (0.53) BRAF
SCHEMBL6223985 0.75 NPC1 (0.54) IKBKBCDK2CDK4CDK1SRC
SCHEMBL1348425 0.74 TSHR (0.73) IKBKBTSHRNPSR1GAASIGMAR1
SCHEMBL4060312 0.74 CDK1 (0.72) CDK2CDK4CDK1CCNB1
SCHEMBL3521886 0.73 IKBKB (0.73) IKBKBCDK2CDK4CDK1
SCHEMBL1632241 0.73 SRC (0.52) SRCSIGMAR1
SCHEMBL4061525 0.73 CDK1 (0.56) IKBKBCDK2CDK4CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008068507-A2 2 -PHENYLAMINO, 6- (PYRID-3-YL) QUINAZOLINE DERIVATIVES AS RAF-PROTEIN KINASE INHIBITORS IN CANCER TREATMENT ASTRAZENECA AB (SE) 2008-06-12 — — WO claimed
Send feedback